𝔖 Bobbio Scriptorium
✦   LIBER   ✦

564 NEOADJUVANT SORAFENIB DECREASES T-REGULATORY CELLS INTRATUMORALLY IN RENAL CELL CARCINOMA (RCC) PATIENTS

✍ Scribed by A. Stillebroer; J.F.M. Jacobs; I.M.E. Desar; P.F.A. Mulders; W.T.A. Van Der Graaf; U.M. De Vries; C.M.L. Van Herpen

Book ID
119621292
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
93 KB
Volume
9
Category
Article
ISSN
1569-9056

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Sorafenib reduces the percentage of tumo
Sorafenib reduces the percentage of tumour infiltrating regulatory T cells in renal cell carcinoma patients
✍ Ingrid M.E. Desar; J. (Hans) F.M. Jacobs; Christina A. Hulsbergen-vandeKaa; Wim πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 335 KB πŸ‘ 2 views

## Abstract Tyrosine kinase inhibitors (TKIs) as sorafenib are known to reduce the number of immunosuppressive regulatory T cells (Tregs) in the peripheral blood and thereby shifting the immune balance to a more stimulating setting. The effect of sorafenib on intratumoural Tregs is unclear but impo

Increased intratumoral regulatory T cell
Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients
✍ Jia Zhou; Tong Ding; Weidong Pan; Ling-yan Zhu; Lian Li; Limin Zheng πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 376 KB

## Abstract Immunosuppression mediated by regulatory T cells (Tregs) is a key facilitator of tumor immune evasion, but the source of these Tregs and their contribution to human cancer progression remains unclear. This study investigated the properties of FoxP3^+^ Tregs, their prognostic value in pa